https://www.selleckchem.com/pr....oducts/ory-1001-rg-6
05 or P less then 0.01). Both drugs increased the serum levels of Ach and decreased the serum levels of Aβ42 and Tau (all P less then 0.05). There was no significant difference in these variables between the two groups, which showed that JYF was not inferior to donepezil. No obviously significant changes were observed in the ADL. No severe adverse events were observed in both groups. CONCLUSION The effect and safety of JYF for the treatment of AD were not inferior to those of donepezil.OBJECTIVE To investigate protective effect
Like
Comment
Share
